Weight Loss Efficacy of Cagrilintide and Semaglutide gutsandgrowth Weight Loss Efficacy of Cagrilintide and Semaglutide gutsandgrowth Emerging pharmacotherapies for obesity: A systematic review Pharmacological Reviews Coadministered Cagrilintide and Semaglutide in Adults with Overweight or Obesity New England Journal of Medicine Cagrilintide (AM833) Long acting amylin analog. Beta cells make TWO hormones: insulin and amylin. Amylin slows stomach emptying and reduces appetite. Cagrilintide is a long acting synthetic amylin designed for once weekly dosing For an adult with type 2 diabetes mellitus who requires substantial weight loss, what are the recommended use, dosing, regulatory approval status, and contraindications of tirzepatide compared with cagrilintide, and what alternative